DMP Pharmaceuticals Corp.
September 27, 2023 - by Joey Ramson
$DMK is down over 20% as of now after finishing up big yesterday on news that the company received a patent in Canada for an opioid intended to treat drug addiction. The stock has been steadily declining since the end of February this year when the price was around $20. It now sits at around $0.60
